Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentasa Sachet 4g in Small Bowel Crohn's Disease
NCT00245505Phase 3Terminated
- Sponsor
- Ferring Pharmaceuticals
- Start
- Feb 2009
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in Crohn's disease, sponsored by Ferring Pharmaceuticals. Started Feb 2009; status: terminated.
02
Drugs
Salcrozine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00245505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245505.